Article - Issue 55
Predictive AI and ML Models in Drug Development
Article - Issue 55
GenAI's Impact on Reshaping the Pharma Industry
Article - Issue 55
The AI Revolution in Pharma
Article - Issue 55
Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...
GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections
Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced
Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing
BioAI an emerging biotech company applying multimodal artificial intelligence to novel biomarker
Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...
Incheon, South Korea
Suntec Convention & Exhibition Centre, Singapore
Basel, Switzerland
Boston, MA, USA
Singapore
Tokyo, Japan
Boston, MA, USA
Jakarta Barat, Indonesia
Senior Director - IT, Elevance Health
Result-driven Leader
Protein Biochemist
President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre
Assistant Professor, Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy
Professor and Head of Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University)
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Department of Chemistry and Biochemistry, California State University, Fullerton, USA.
Faculty of Dentistry, University of Toronto, Toronto, Canada.
College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipewg, Manitoba, Canada.
Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, Aveiro, Portugal.
Research Institute of Oncology and Hematology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Canada.
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of SingaporeIn an era where medical science is advancing at an unprecedented pace the integration of bioinformatics has emerged as a gamechanger offering new avenues for understanding diagnosing and treating cancer
AbstractPharmaceuticals are not currently tested for transgenerational and epigenetic side effects The use of vertebrates as preclinical research models is limited by their long generation times low numbers of progeny and ethical concerns In contrast invertebrates such as insects breed rapidly produce many offspring and are more ethically acceptable allow
AbstractCough and cold is the most common cause for hospital visits and so is the use of cough and cold medication CCM A cough and cold medication has been considered to contain a single ingredient SI or multiple ingredients MI like promethazine PRZ chlorpheniramine CPM pseudoephedrine PS phenylephrine PE diphenhydramine DPH dextromethor
Scientists at The University of Texas at El Paso have discovered a groundbreaking pharmaceutical compound Thiophene F which has demonstrated efficacy in eliminating leukaemia and lymphoma cancer cells
SummaryRare diseases those afflicting fewer than individuals in the United States individually affect relatively small groups of patients But taken together rare diseases afflict as many as million Americans nearly of the US population To date as many as rare diseases have been identified and roughly new rare diseases are described annually
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster
